Observational Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 16293-16299
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16293
Table 1 Descriptive details and diagnoses of the ROME III and ROME II cohorts1
Descriptive detailsROME III cohortn = 100ROME II cohortn = 160
Mean ± SDMean ± SD
Age (yr)25.1 ± 7.924.7 ± 6.4
Current BMI kg/m218.5 ± 3.818.2 ± 3.6
Lowest BMI kg/m215.9 ± 2.915.7 ± 4.2
QOL ED score216.0 ± 3.516.3 ± 3.2
ED diagnoses%%
AN-R2726
AN-P2020
BN918
EDNOS-R1411
EDNOS-P3025
Table 2 Prevalence of functional gastrointestinal disorders categories for ROME III (with and without 6-mo requirement) and ROME II (with 3-mo requirement)
ROME III cohort (n = 100)
ROME II cohort (n = 160)
With 6-mo requirementWith 3-mo requirementPresent 3 mo or more
Region
A: Functional Esophageal Disorders34%55%40%
B: Functional Gastroduodenal Disorders62%79%16%
Without cyclic vomiting45%60%
C: Functional Bowel Disorders77%98%88%
Without unspecified bowel disease53%80%
D: Functional Abdominal Pain Syndrome3%6%4%
E: Functional Gallbladder and Sphincter of Oddi Disorders0%2%
F: Functional Anorectal Disorders116%20%35%
Total
At least one FGID83%94%
At least 3 FGIDs34%36%
Table 3 Prevalence of individual functional gastrointestinal disorders present in ROME III with and without 6-mo presence requirement and the prevalence of these in ROME II
ROME III (n = 100)
ROME II (n = 160)
With 6-mo requirementWith 3-mo requirementPresent 3 mo or more
A1: Functional Heartburn122%26%24%
A2: Functional Chest Pain of Presumed Esophageal Origin18%17%4%
A3: Functional Dysphagia16%16%9%
A4: Globus11%2%5%
B1: Functional Dyspepsia10%57%7%
B1a: Postprandial Distress Syndrome145%72%-
B2a: Aerophagia114% (a,b combined)18% (a,b combined)11%
B2b: Unspecified Excessive Belching1-
B3a: Chronic idiopathic nausea110%14%-
B3c: Cyclic vomiting syndrome17%19%-
B4: Rumination Syndrome in Adults17%7%2%
C1: Irritable Bowel Syndrome141%57%45%
C2: Functional Bloating11%3%30%
C3: Functional Constipation111%27%26%
C5: Unspecified Functional Bowel Disorder124%18%-
F1: Functional Fecal Incontinence (3 mo)15%15%11%
F2a: Chronic Proctalgia15%5%-
F2b: Proctalgia Fugax (3 mo)11%11%21%
Table 4 Prevalence of functional gastrointestinal disorders categories for ROME III (with 6-mo requirement) by eating disorder sub-types
ROME III cohort
AN-R (n = 27)AN-P (n = 20)BN (n = 9)EDNOS-R (n = 14)EDNOS-P (n = 30)
A: Functional Esophageal Disorders14.8%35.0%33.3%42.9%46.7%
B: Functional Gastroduodenal Disorders44.4%75.0%88.9%42.9%70.0%
Without cyclic vomiting44.4%60.0%44.4%35.7%40.0%
C: Functional Bowel Disorders63.0%85.0%77.8%85.7%80.0%
Without unspecified bowel disease40.7%65.0%55.6%50.0%56.7%
D: Functional Abdominal Pain Syndrome7.4%5.0%0.0%0.0%0.0%
E: Functional Anorectal Disorders17.4%10.0%11.1%35.7%20.0%
Total
At least one FGID70.4%95.0%88.9%85.7%83.3%
At least 3 FGIDs18.5%40.0%33.3%35.7%43.3%
Table 5 Behavioural and psychological predictors of the commonly occurring ROME III functional gastrointestinal disorders among eating disorder patients
ROME III FGIDPredictorsBWaldυPOR95%CI
A1: Functional HeartburnSomatisation0.135.3110.0211.141.021.27
B1a: Postprandial Distress SyndromeStarvation0.586.9910.0081.791.162.76
Exercise-0.576.2310.0130.560.360.88
Depression0.674.7310.0301.071.011.14
C1: Irritable Bowel SyndromeLaxatives0.465.0510.0251.581.062.35
C5: Unspecified Functional Bowel DisorderSomatisation-0.197.2110.0070.830.730.95